Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Nissinen, T. A.
Poikonen, A. R.
Hulmi, J. J.
Text and Data Mining valid from 2016-09-26
17 March 2016
12 August 2016
26 September 2016
The authors declare no competing financial interests.